Login

Paion advancing its general anesthesia drug candidate - Wolfgang Soehngen, CEO, Paion 00:00:00

Share On Facebook Share On Twitter

Paion advancing its general anesthesia drug candidate

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating the Allergy Therapeutics landscape: Insights into Market Expansion and Financial Strength |Manuel Llobet, CEO, Allergy Therapeutics PLC.
00:10:00
Private Markets Outlook: Global Trends, India's Potential, and Investment Strategy | Rishi Kapoor, CO-CEO, Investcorp Inc.
00:10:00
C3 Metals: Exploring New Opportunities in Peru and Jamaica with Dan Simons
00:10:00
Exploring the Transition from Hollywood to Anti-Aging: Insights from a Former Columbia Pictures Executive Turned Nutraceutical CEO | Robert Fried ,CEO, Chromadex Corp.
00:10:00
Canadas Zinc Corp: Advancing Zinc-Lead-Silver Projects in British Columbia
00:10:00
Steering Toward Sustainable Profitability After Near Bankruptcy | Calin Rovinescu, CEO, Air Canada.
00:10:00
Xspray Pharma CEO Presents at Naventus Life Science Summit 2021 | PER ANDERSSON , CEO OF XSPRAY PHARMA AB
00:10:00
A Legacy in Private Equity and Economic Insights | John K. Castle, Chairman and CEO, Castle Harlan.
00:10:00
Exploring Green Metals: Focus on High-Grade Nickel-Copper Projects and Strategic Development
00:10:00
Sébastien Bazin on the Pathway to Net Positive Hospitality | Sébastien Bazin, CEO , Accor SA.
00:10:00
investing in Miami with his new incubator Pareto|Jon Oringer,Co-Founder,Shutterstock
00:10:00
Embracing the Future: Introducing Kotak Technology Fund | Nilesh Shah, CEO , Kotak Mutual Fund .

© 2017 - Neuhu+